AM

Aby Mathew

Advisor at RoosterBio

Dr. Mathew is part of the founding team and is co-developer of BioLife’s biopreservation media solutions. Dr. Mathew has been researching low temperature biopreservation since 1994, and his studies contributed to the development of BioLife’s commercial HypoThermosol® and CryoStor product platforms and intellectual property foundation. He established BioLife’s initial Quality system and is currently BioLife’s Senior Vice President & Chief Technology Officer. Dr. Mathew is a member of the Board of Directors, and Advisory Panel, of the Parent’s Guide to Cord Blood Foundation, the Scientific Advisory Board of HemaCare Corporation, the founding Board of Directors of the Cord Blood Association, the NIST-AMTech National Cell Manufacturing Consortium and the California Institute for Regenerative Medicine (CIRM) Clinical Advisory Panel. He holds a Ph.D. from Binghamton University and a B.S. from Cornell University.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


RoosterBio

RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable Regenerative Medicine industry, one customer at a time.


Industries

Employees

11-50

Links